Overview

Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome

Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the effects of Azor (a combination of amlodipine and olmesartan) with Hyzaar ( a combination of losartan and hydrochlorothiazide) on the thin lining on the inside of blood vessels. These cells help keep blood vessels healthy and blood pressure normal.
Phase:
Phase 4
Details
Lead Sponsor:
InVasc Therapeutics, Inc.
Treatments:
Amlodipine
Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
Hydrochlorothiazide
Losartan
Olmesartan
Olmesartan Medoxomil
Spironolactone